Literature DB >> 26548930

Mitochondria-targeted drug delivery system for cancer treatment.

Zhi-Peng Chen1, Man Li1, Liu-Jie Zhang1, Jia-Yu He1, Li Wu1, Yan-Yu Xiao2, Jin-Ao Duan1, Ting Cai2, Wei-Dong Li1.   

Abstract

Mitochondria are one type of the major organelles in the cell, participating in a variety of important physiological and biochemical processes, such as tricarboxylic acid cycle, fatty acid metabolism and oxidative phosphorylation. Meanwhile, it also happens to be the key regulator of apoptosis by triggering the complex cell-death processes through a variety of mechanisms. Since it plays a pivotal role in cell-death, a mitochondria-targeted treatment strategy could be promising for cancer therapy. In this comprehensive review, we focused on the mechanisms of mitochondrial targeting and a variety of strategies to realize the purpose of mitochondrial targeting, including that based on the use of lipophilic cations, and mitochondrial targeting signal peptides (MTS) as well as cell-penetrating peptides (CPPs). Then on this basis we present some several developed strategies for multifunctional mitochondria-targeted agents so as to achieve the good anti-cancer therapeutic effects.

Entities:  

Keywords:  Mitochondria-targeted; multifunctional; multilevel targeting; nanomedicine; peptides

Mesh:

Substances:

Year:  2015        PMID: 26548930     DOI: 10.3109/1061186X.2015.1108325

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  15 in total

Review 1.  Biomineralized hybrid nanoparticles for imaging and therapy of cancers.

Authors:  Kyung Hyun Min; Hong Jae Lee; Sang Cheon Lee; Kyeongsoon Park
Journal:  Quant Imaging Med Surg       Date:  2018-08

2.  A Phosphinate-Containing Fluorophore Capable of Selectively Inducing Apoptosis in Cancer Cells.

Authors:  Xinqi Zhou; Yuan Fang; Lauren Lesiak; Cliff I Stains
Journal:  Chembiochem       Date:  2019-05-03       Impact factor: 3.164

3.  Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma.

Authors:  Dong Zhang; Yi Duan; Jinjing Cun; Qifeng Yang
Journal:  Front Genet       Date:  2019-03-28       Impact factor: 4.599

4.  In vitro mitochondrial-targeted antioxidant peptide induces apoptosis in cancer cells.

Authors:  Wei Zhan; Xin Liao; Lianghe Li; Zhongsheng Chen; Tian Tian; Lei Yu; Zupeng Chen
Journal:  Onco Targets Ther       Date:  2019-09-06       Impact factor: 4.147

5.  Photoactivatable prodrug for simultaneous release of mertansine and CO along with a BODIPY derivative as a luminescent marker in mitochondria: a proof of concept for NIR image-guided cancer therapy.

Authors:  Rajeshwari Tiwari; Prashant S Shinde; Sreejesh Sreedharan; Anik Kumar Dey; Katherine A Vallis; Santosh B Mhaske; Sumit Kumar Pramanik; Amitava Das
Journal:  Chem Sci       Date:  2020-12-23       Impact factor: 9.825

6.  Extracts of Artocarpus communis Induce Mitochondria-Associated Apoptosis via Pro-oxidative Activity in Human Glioblastoma Cells.

Authors:  Chiang-Wen Lee; Lee-Fen Hsu; Ming-Hsueh Lee; I-Ta Lee; Ju-Fang Liu; Yao-Chang Chiang; Ming-Horng Tsai
Journal:  Front Pharmacol       Date:  2018-05-02       Impact factor: 5.810

7.  Mitochondria-targeted aggregation induced emission theranostics: crucial importance of in situ activation.

Authors:  Weon Sup Shin; Min-Goo Lee; Peter Verwilst; Joung Hae Lee; Sung-Gil Chi; Jong Seung Kim
Journal:  Chem Sci       Date:  2016-06-07       Impact factor: 9.825

8.  Prognostic value and potential function of splicing events in prostate adenocarcinoma.

Authors:  Zhi-Guang Huang; Rong-Quan He; Zeng-Nan Mo
Journal:  Int J Oncol       Date:  2018-09-17       Impact factor: 5.650

9.  Compound Fuling Granule Suppresses Ovarian Cancer Development and Progression by disrupting mitochondrial function, galactose and fatty acid metabolism.

Authors:  Shanming Ruan; Zhiqian Zhang; Xinxin Tian; Dawei Huang; Wenhong Liu; Bo Yang; Minhe Shen; Fangfang Tao
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

10.  Mitofusin2 Induces Cell Autophagy of Pancreatic Cancer through Inhibiting the PI3K/Akt/mTOR Signaling Pathway.

Authors:  Ran Xue; Qinghua Meng; Di Lu; Xinjuan Liu; Yanbin Wang; Jianyu Hao
Journal:  Oxid Med Cell Longev       Date:  2018-06-26       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.